Clinical Trials Logo

Filter by:
NCT ID: NCT01802814 Completed - Clinical trials for Acute Lymphoblastic Leukemia (ALL)

International Study for Treatment of Standard Risk Childhood Relapsed ALL 2010

Start date: May 2014
Phase: Phase 3
Study type: Interventional

The main goal of this study is to improve the outcome of children and adolescents with standard risk (SR) first relapsed acute lymphoblastic leukemia. Furthermore, goal is to set up a large international study group platform allowing for optimization of standard treatment strategies and integration of new agents.

NCT ID: NCT01802788 Completed - Clinical trials for Aortic Valve Stenosis

5 Year Observation of Patients With PORTICO Valves

PORTICO-1
Start date: April 16, 2013
Phase:
Study type: Observational

The purpose of this clinical investigation is to further assess the performance and safety profile of the commercially-available Porticoâ„¢ TAVI System in patients with severe symptomatic aortic stenosis.

NCT ID: NCT01802775 Completed - Clinical trials for Peripheral Arterial Disease

Edoxaban in Peripheral Arterial Disease

ePAD
Start date: February 6, 2013
Phase: Phase 2
Study type: Interventional

This study is a randomized, open-label, blinded endpoint, parallel-group, active-control, multi-center, proof-of-concept study in subjects with Peripheral Arterial Disease (PAD), designed to assess the safety and potential efficacy of adding edoxaban to aspirin following femoropopliteal endovascular intervention, with or without stent placement, relative to current treatment practice with clopidogrel and aspirin.

NCT ID: NCT01802593 Terminated - Crohn's Disease Clinical Trials

Comparison of 2 Immunomodulator Withdrawal Schemes for Infliximab Monotherapy in Active Pediatric Crohn's Disease After Thiopurine Failure

WITHDRAW
Start date: February 2013
Phase: Phase 4
Study type: Interventional

The goal of the present study is to evaluate the best regimen for infliximab monotherapy, and to evaluate if limited combination therapy with IFX and an Immunomodulator for the first 6 months of therapy, in prior Immunomodulator failures, is superior to monotherapy with Immunomodulator cessation from the second infusion, in preventing loss of remission to IFX.

NCT ID: NCT01802047 Withdrawn - Prematurity Clinical Trials

Impact of Different Electric Pumping Modalities on Milk Volume Production in Mothers of Preterm Infants

Start date: August 2013
Phase: N/A
Study type: Interventional

Initiating and sustaining breastfeeding are common challenges in neonatal units. It is known that hindmilk expressed at the end of the expression session has a higher fat content. Previous studies have shown that simultaneous pumping is more effective at producing milk than sequential pumping. However this approach is often felt uncomfortable by the mothers, and sequential pumping is preferred. The purpose of this study is to determine which modality of milk expression by electric pump is the most efficient and productive when sequential pumping is used.This is done by assessing the milk volume expressed per expression and its macronutrients content.

NCT ID: NCT01801514 Completed - Clinical trials for Other Conditions That May Be A Focus of Clinical Attention

Applications of Dual-Energy Computed Tomography

Start date: November 2012
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate the feasibility of multilayer detection-based dual energy computed tomography scanner and to assess the added diagnostic value of dual energy applications

NCT ID: NCT01801020 Withdrawn - Sepsis Clinical Trials

Different Modes of Temperature Measurement in the Emergency Department

Start date: March 2013
Phase: Phase 3
Study type: Interventional

Introduction: Temperature measurement is a crucial and integral element in the assessment of the emergency department patients. The basis of triage and treatment is often directly influenced by temperature measurement. The finding of hyper/hypothermia may differentiate between a simple urinary tract infection and pyelonephritis, or in more extreme cases may discern "weakness" in the elderly from sepsis. This brief encounter of temperature measurement may be paramount to the medical treatment of the emergency department patient. The investigators will explore the different modes of temperature measurements in emergency department patients.

NCT ID: NCT01800565 Recruiting - Clinical trials for Precocious Puberty, Gonadotropin-dependent

First-Voided Urinary LH vs. GnRH-stimulation in Differentiating Slowly- From Rapidly Progressive-Precocious Puberty

Start date: June 2006
Phase: N/A
Study type: Interventional

Precocious puberty (PP) in girls is classically defined by the onset of secondary sexual characteristics before eight years of age, but subsequent pubertal maturation can be quite varied. In many girls, PP takes a rapid course of progression (rapidly progressive precocious puberty; RP-PP) with an early menarche and fusion of the epiphyseal growth plates, leading eventually to a reduced final height if not treated. In a subset of girls with PP however, the growth rate slows to normal for age, skeletal maturation progresses in accordance with chronological age and there is little to no risk of impairment of final height (slowly progressive precocious puberty; SP-PP). Other conditions of non-progressive PP include premature breast budding and unsustained PP that is characterized by a spontaneous regression of sexual precocity. Due to their benign course, slowly progressive (SP) PP and other non-progressive forms of PP do not warrant therapy with GnRH agonists. Differentiating these forms from RP-PP is therefore essential to prevent unnecessary intervention in a population that accounts for at least 50% of girls with PP. A distinction between these forms of PP may be difficult on clinical grounds however, since all these patients may present initially as isolated breast development. The gold standard for the diagnosis of true (central) PP is the measurement of gonadotropins following GnRH stimulation test. There is however an overlap between prepubertal and early pubertal values and between girls with premature breast budding and progressive PP. It was suggested therefore that progressive pubertal development and growth acceleration should be documented over a 3- to 6-months period before GnRHa therapy in initiated. More than a decade ago several studies demonstrated that urinary gonadotropins are age related and significantly increased during puberty. It has been suggested that urinary gonadotropins measurements can be used for differential diagnosis of pubertal disorders. This is based on the assumption that gradual elevation of nocturnal LH secretion prior to and at the onset of puberty can be reflected by first-voided urinary LH (ULH). In this prospective study, the investigators aimed to evaluate the value of first-voided ULH measurements in predicting pubertal course and differentiating SP-PP from RP-PP, by comparison to GnRH-stimulated gonadotropins.

NCT ID: NCT01799668 Not yet recruiting - Clinical trials for Diagnosis, Psychiatric

Therapists' Preferences for Client Characteristics and Their Influence on the Therapeutic Alliance

Start date: February 2013
Phase: N/A
Study type: Observational [Patient Registry]

The research will examine psychotherapists' preferences for theoretical client characteristics, such as age, gender, personality characteristics and symptoms. The research will also examine the preferences' influence on the therapeutic alliance, from the therapist's and the client's point of view.

NCT ID: NCT01799655 Completed - Chest Pain Clinical Trials

Does Vitamin D Deficiency Associated With Hypercoagulability & Increased Thrombin Generation?

Start date: April 2013
Phase: N/A
Study type: Observational [Patient Registry]

Cardiovascular disease is the most common cause of mortality and morbidity worldwide. Recently, a growing body of evidence has identified Vitamin D deficiency as a potential risk factor for cardiovascular disease. Therefore, there is an increasing interest to explore the mechanism in which vitamin D deficiency affect the cardiovascular system. The investigators want to examine the relationship between serum vitamin D levels and the coagulation status in the subjects. The applied the calibrated automated thrombogram (CAT) to assess thrombin generation in plasma as a measure of overall thrombotic activity, and thus to suggest a mechanism that may explain the link between vitamin D deficiency and cardiovascular disease. Our study population are going to include 100 patients from the internal departments in Emek hospital, who present with chest pain but without acute coronary syndrome (ACS). The investigators will take blood samples from the subjects to measure the serum vitamin D levels and the generation of thrombin. The patients will be divided into four groups according to the level of vitamin D to evaluate the effect of vitamin D levels in the blood on coagulability and thrombotic activity in these patients.